160
Participants
Start Date
August 31, 2005
Primary Completion Date
March 31, 2008
Study Completion Date
March 31, 2008
17-b-estradiol
2mg oral daily for 6 months
17-b-estradiol + medroxyprogeterone acetate
2mg E2 + 5mg MPA daily for 6 months
17-b-estradiol hemihydrate
1 mg skin gel daily for 6 months
placebo pill + gel
placebo daily for 6 months
Helsinki University Hospital, Department of Obstetrics and Gynecology, Helsinki
Collaborators (1)
Päivikki and Sakari Sohlberg Foundation, Finland
OTHER
Emil Aaltonen Foundation
OTHER
Finnish Medical Foundation
NETWORK
University of Helsinki
OTHER